Principal Financial Group Inc. Purchases Shares of 230,975 Astrana Health, Inc. (NASDAQ:ASTH)

Principal Financial Group Inc. acquired a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 230,975 shares of the company’s stock, valued at approximately $13,383,000. Principal Financial Group Inc. owned 0.41% of Astrana Health at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. GAMMA Investing LLC bought a new stake in Astrana Health in the 3rd quarter valued at approximately $34,000. Nisa Investment Advisors LLC acquired a new stake in shares of Astrana Health in the third quarter valued at approximately $35,000. KBC Group NV bought a new stake in shares of Astrana Health in the third quarter worth $70,000. Quarry LP acquired a new position in Astrana Health during the third quarter worth $77,000. Finally, Quest Partners LLC bought a new position in Astrana Health in the third quarter valued at $133,000. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Stock Down 2.4 %

ASTH stock opened at $32.72 on Friday. Astrana Health, Inc. has a 1-year low of $32.21 and a 1-year high of $63.20. The business’s 50 day simple moving average is $44.45 and its 200 day simple moving average is $47.57. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $1.84 billion, a PE ratio of 25.17, a PEG ratio of 1.80 and a beta of 1.13.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period in the prior year, the firm earned $0.47 earnings per share. As a group, research analysts anticipate that Astrana Health, Inc. will post 1.16 EPS for the current year.

Wall Street Analysts Forecast Growth

ASTH has been the subject of a number of recent research reports. KeyCorp assumed coverage on shares of Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating for the company. BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Robert W. Baird boosted their price target on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Macquarie raised Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, TD Cowen initiated coverage on shares of Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 target price on the stock. Two analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Astrana Health has an average rating of “Moderate Buy” and an average target price of $65.17.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.